SCHEMBL10153320

SCHEMBL10153320

c1cc2c3c(c1)CCN3CC2

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 3/20 0.67
HTR2B P41595 1/20 0.50
HTR1A P08908 1/20 0.46
ACHE P22303 1/20 0.43
MAPT P10636 2/20 0.42
MEN1 O00255 2/20 0.42
ALDH1A1 P00352 2/20 0.42
ALOX15 P16050 2/20 0.42
KMT2A Q03164 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
NOTUM Q6P988 1/20 0.41
MAOA P21397 2/20 0.41
MAOB P27338 2/20 0.41
DRD2 P14416 1/20 0.41
DRD1 P21728 1/20 0.41
DRD4 P21917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2338214 0.91 HTR2C (0.65) HTR2CHTR2BHTR1AACHEMAPT
SCHEMBL4507606 0.89 HTR2C (0.66) HTR2CHTR2BHTR1AACHEKMT2A
SCHEMBL29494128 0.89 HTR2C (0.66) HTR2CHTR2BHTR1AACHEKMT2A
SCHEMBL60540 0.84 HTR2C (0.69) HTR2CHTR2BHTR1AACHEMAPT
SCHEMBL29876743 0.83 HTR2C (0.51) HTR2CHTR2BHTR1AACHEMAPT
Bromide SCHEMBL8863742 0.82 HTR2C (0.67) HTR2CHTR2BHTR1AACHEMAPT
SCHEMBL4492996 0.80 HTR2C (0.68) HTR2CHTR2BHTR1AACHEMEN1
SCHEMBL9037387 0.79 HTR2C (0.47) HTR2CHTR2BHTR1AACHEMAPT
SCHEMBL2265625 0.79 HTR2C (0.47) HTR2CHTR2BACHEMAPTMEN1
SCHEMBL22770710 0.77 HTR2C (0.61) HTR2CHTR2BHTR1AACHEMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8421066-B2 Organic electroluminescence device UDC IRELAND LIMITED (IE) 2013-04-16 US disclosed
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2012-07-12 US disclosed
US-8174002-B2 Organic electroluminescence device FUJIFILM CORPORATION (JP) 2012-05-08 US disclosed
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE FUJIFILM CORPORATION (JP) 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100051928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 HTR2C 4237/4885HTR2B 3446/4885HTR1A 1665/4885
US-20120178928-A1 ORGANIC ELECTROLUMINESCENCE DEVICE L1CAM, CHRM1, LEF1 HTR2C 4237/4885HTR2B 3446/4885HTR1A 1665/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.